DK121510B - Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5(10)>-østrener. - Google Patents

Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5(10)>-østrener.

Info

Publication number
DK121510B
DK121510B DK303365A DK303365A DK121510B DK 121510 B DK121510 B DK 121510B DK 303365 A DK303365 A DK 303365A DK 303365 A DK303365 A DK 303365A DK 121510 B DK121510 B DK 121510B
Authority
DK
Denmark
Prior art keywords
estreners
methyl
preparation
therapeutically active
therapeutically
Prior art date
Application number
DK303365A
Other languages
English (en)
Inventor
Jongh H De
Vliet N Van
Original Assignee
Org Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Org Nv filed Critical Org Nv
Publication of DK121510B publication Critical patent/DK121510B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK303365A 1964-06-17 1965-06-16 Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5(10)>-østrener. DK121510B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6406849A NL6406849A (da) 1964-06-17 1964-06-17

Publications (1)

Publication Number Publication Date
DK121510B true DK121510B (da) 1971-10-25

Family

ID=19790327

Family Applications (2)

Application Number Title Priority Date Filing Date
DK303365A DK121510B (da) 1964-06-17 1965-06-16 Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5(10)>-østrener.
DK501870A DK125773B (da) 1964-06-17 1970-10-01 7α-methyl-Δ<5(10)>-østrener til anvendelse som svangerskabsforebyggende midler.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK501870A DK125773B (da) 1964-06-17 1970-10-01 7α-methyl-Δ<5(10)>-østrener til anvendelse som svangerskabsforebyggende midler.

Country Status (9)

Country Link
BE (1) BE665515A (da)
BR (1) BR6570426D0 (da)
CH (1) CH487874A (da)
DE (1) DE1543270A1 (da)
DK (2) DK121510B (da)
FR (1) FR1604116A (da)
GB (1) GB1107553A (da)
NL (1) NL6406849A (da)
SE (1) SE336789B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6901532A (da) * 1969-01-30 1970-08-03
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
DK125773B (da) 1973-05-07
NL6406849A (da) 1965-12-20
SE336789B (da) 1971-07-19
FR1604116A (en) 1971-07-12
BE665515A (da)
BR6570426D0 (pt) 1973-08-14
CH487874A (de) 1970-03-31
GB1107553A (en) 1968-03-27
DE1543270A1 (de) 1969-07-31

Similar Documents

Publication Publication Date Title
DK128353B (da) Analogifremgangsmåde til fremstilling af terapeutisk aktive bis-chromoner.
DK111956B (da) Fremgangsmåde til fremstilling af 3,5-dioxo-17β-hydroxy-4,5-seco-Δ&lt;9&gt;-estren.
DK114553B (da) Fremgangsmåde til fremstilling af biologisk aktive 7α-methyl-3-keto-Δ&lt;5(10)&gt;-østrener.
DK123170B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 3-oxo-7α-methyl-Δ&lt;4,9,11&gt;-estratriener.
DK117635B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler.
DK115108B (da) Fremgangsmåde til fremstilling af 2-amino-benzophenon-β-oximer.
DK115547B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK118825B (da) Fremgangsmåde til fremstilling af adrenocorticotropt virksomme tricosa- eller tetracosapeptider.
DK121510B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5(10)&gt;-østrener.
DK114267B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 17β-trialkylsiloxy-Δ&lt;4&gt;-androstener eller - estrener.
DK116658B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5&gt;-østrener.
DK117488C (da) Fremgangsmåde til fremstilling af terapeutisk aktive 2α-3α-epithio-5α-androstaner.
DK112235B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 21-dicyclohexylmethylcarbonater af 21-hydroxy-Δ&lt;4&gt;-pregnen-17α-ol-3,20-dioner.
DK116294B (da) Analogifremgangsmåde til fremstilling af 4&#39;-demethyl-epipodophyllotoxin.
DK104301C (da) Fremgangsmåde til fremstilling af 3-hydroksy- eller 3-karbonhydridoksy-Δ&lt;1,3,5(10)&gt;-19-nor-steroider.
DK122071B (da) Analogifremgangsmåde til fremstilling af methylenbutyrylphenoler.
DK114980B (da) Fremgangsmåde til fremstilling af sulfamylanthranilsyreamider.
DK129197B (da) Fremgangsmåde til fremstilling af 10-carbonhydridsubstituerede 5-hydroxy-13β-alkyl-Δ&lt;9(11)&gt;-gonener.
DK111487B (da) Fremgangsmåde til fremstilling af 17β-hydroxy- eller 17β-alkanoyloxy-3-keto-Δ&lt;4,8(14),9&gt;-gonatriener.
DK112318B (da) Fremgangsmåde til fremstilling af 2-benzensulfonylamidopyrimidiner.
DK111891B (da) Fremgangsmåde til fremstilling af 5-oxo-17α-methyl-20-hydroxy-(des-A)-19-nor-pregna-9-en.
DK115694B (da) Fremgangsmåde til fremstilling af α-dithioler.
DK109329C (da) Fremgangsmåde til fremstilling af Δ&lt;4&gt;-6α-alkyl-19-nor-pregnener.
DK106090C (da) Fremgangsmåde til fremstilling af 3-halogen-Δ&lt;5&gt;-19-nor-androstener.
DK114552B (da) Fremgangsmåde til fremstilling af 1-metyl-Δ&lt;1&gt;-5α-androsten-17β-ol-3-on-17-estere.